Clinical trial
Menevit Study: Menevit Anti-Oxidant Therapy for the Treatment of Male…
NCT00100269 · Repromed, Other · Completed
Key facts
| NCT number | NCT00100269 |
|---|---|
| Title | Menevit Study: Menevit Anti-Oxidant Therapy for the Treatment of Male Infertility |
| Official title | A Randomized Control Trial of the Menevit Anti-Oxidant Therapy for the Treatment of Male Infertility |
| Lead sponsor | Repromed, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infertility, Male, Oxidative Stress |
| Intervention type | Drug |
| Interventions | Menevit anti-oxidant |
| Enrollment | 60 |
| Start date | Dec 1, 2004 |
| Completion | Mar 1, 2006 |
| First posted | Dec 28, 2004 |
| Last update posted | May 3, 2006 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: